Clinical Trial Update: Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lenalidomide to chlorambucil as first-line therapy in elderly patients with B-cell chronic lymphocytic leukemia; completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: B-Cell Chronic Lymphocytic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2016-12-21